METHOTREXATE (MTX) - PHARMACOLOGY IN PATIENTS RECEIVING INTENSIVE MTX/6MERCAPTOPURINE (6MP) CONSOLIDATION FOR ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - A PEDIATRIC ONCOLOGY GROUP-STUDY

被引：0
|
作者：
GRAHAM, M
CAMITTA, B
LAUER, S
LEVENTHAL, B
CASPER, J
CIVIN, C
CHEO, D
ZUHARUK, M
机构：
[1] JOHNS HOPKINS UNIV HOSP,CTR ONCOL,BALTIMORE,MD 21205
[2] MED COLL WISCONSIN,MIDWEST CHILDRENS CANC CTR,MILWAUKEE,WI 53226
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1988年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：226 / 226
页数：1
相关论文
共 50 条
  • [21] Factors associated with nonadherence to oral 6-mercaptopurine (6MP) in children with acute lymphoblastic leukemia (ALL): A report from Children's Oncology Group (COG) study AALL03N1.
    Landier, Wendy
    Chen, Yanjun
    Hageman, Lindsey
    Kim, Heeyoung
    Bostrom, Bruce C.
    Casillas, Jacqueline N.
    Dickens, David S.
    Evans, William E.
    Maloney, Kelly W.
    Mascarenhas, Leo
    Ritchey, Arthur Kim
    Termuhlen, Amanda M.
    Carroll, William L.
    Relling, Mary V.
    Wong, Florence Lennie
    Bhatia, Smita
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Tolerability of 6-Mercaptopurine (6MP) in Patients with Thiopurine Methyltransferase (TPMT) Heterozygosity in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia (ALL)
    Liu, Chengcheng
    Pei, Deqing
    Cheng, Cheng
    Yang, Jun J.
    Crews, Kristine
    Yang, Wenjian
    Karol, Seth E.
    Jeha, Sima
    Sandlund, John T.
    Ribeiro, Raul C.
    Rubnitz, Jeffrey E.
    Metzger, Monika L.
    Pui, Ching-Hon
    Evans, William E.
    Relling, Mary V.
    BLOOD, 2014, 124 (21)
  • [23] Evaluation of Three Starting Dosage Regimens of 6-Mercaptopurine (6MP) in Maintenance Phase of Acute Lymphocytic Leukaemia (ALL) Patients in a Low Income Country (LIC)
    Gunasekera, D. S.
    Gunarathne, C. R. B.
    Somathilake, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 61 - 61
  • [24] INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE THERAPY FOR NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    CAMITTA, B
    LEVENTHAL, B
    LAUER, S
    SHUSTER, JJ
    ADAIR, S
    CASPER, J
    CIVIN, C
    GRAHAM, M
    MAHONEY, D
    MUNOZ, L
    KIEFER, G
    KAMEN, B
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) : 1539 - 1544
  • [25] Predicting risk for non-adherence to oral 6-mercaptopurine (6MP) in children with acute lymphoblastic leukemia (ALL) results from the Children's Oncology Group AALLO3N1 study.
    Bhatia, Smita
    Chen, Yanjun
    Landier, Wendy
    Hageman, Lindsey
    Yasui, Yutaka
    Relling, Mary V.
    Wong, F. Lennie
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Pharmacogenetic study of methotrexate and 6-mercaptopurine related genes in Korean pediatric patients with acute lymphoblastic leukemia
    Kang, Hyoung Jin
    Seo, Young-Jin
    Lee, Chang Jin
    Kim, Hyery
    Jang, Mi Kyung
    Koh, Sang Hyeok
    Oh, Yongtaek
    Han, Byoung-Don
    Kim, Chul Woo
    Kim, Eun Kyung
    Shin, Hee Young
    Ahn, Hyo Seop
    BLOOD, 2007, 110 (11) : 116B - 116B
  • [27] CLINICOPATHOLOGICAL SIGNIFICANCE OF IMMUNOPHENOTYPIC SUBGROUPS OF B-LINEAGE ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - A PEDIATRIC ONCOLOGY GROUP (POG) STUDY
    SCROGGS, M
    BOYETT, J
    FALLETTA, J
    PULLEN, DJ
    JACKSON, J
    RUSSELL, E
    CRIST, W
    BOROWITZ, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 201 - 201
  • [28] Nonadherence to Oral 6-Mercaptopurine (6MP) in a Multi-Ethnic Cohort of Children with Acute Lymphoblastic Leukemia (ALL) and Its Impact On Relapse - a Children's Oncology Group (COG) Study (AALL03N1)
    Bhatia, Smita
    Landier, Wendy
    Hageman, Lindsey
    Kim, Heeyoung
    Hanby, Cara
    Nancy, Kornegay
    Bostrom, Bruce C.
    Casillas, Jacqueline
    Dickens, David S.
    Maloney, Kelly W.
    Mascarenhas, Leo
    Meza, Jane
    Ritchey, Arthur Kim
    Termuhlen, Amanda M.
    Carroll, William L.
    Wong, F. Lennie
    Relling, Mary V.
    BLOOD, 2012, 120 (21)
  • [29] HIGH-DOSE METHOTREXATE AS PART OF REMISSION MAINTENANCE THERAPY FOR CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP PILOT-STUDY
    FRANKEL, LS
    WANG, YM
    SHUSTER, J
    NITSCHKE, R
    DOERING, EJ
    PULLEN, J
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) : 804 - 809
  • [30] COMPARISON OF PREDNISOLONE, VINCRISTINE, METHOTREXATE AND 6-MERCAPTOPURINE VS 6-MERCAPTOPURINE AND PREDNISONE MAINTENANCE THERAPY IN CHILDHOOD ACUTE-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BERRY, DH
    FERNBACH, DJ
    HERSON, J
    PULLEN, J
    SULLIVAN, MP
    VIETTI, TJ
    CANCER, 1980, 46 (05) : 1098 - 1103
12345